R Möricke

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini et al. · The Lancet · 2017 · 554 citations · Full text

Bone Disease, Bone Health, New Fractures +8

Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double‐Blind, Active Comparator– and Placebo‐Controlled Study

Francisco J. Blanco, R Möricke, Eva Dokoupilová et al. · Arthritis & Rheumatology · 2017 · 172 citations

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Claus‐C. Glüer, Fernando Marín, J. D. Ringe et al. · Journal of Bone and Mineral Research · 2013 · 170 citations · Full text

Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis

Robert R. Recker, Fernando Marín, Sophia Ish‐Shalom et al. · Journal of Bone and Mineral Research · 2009 · 117 citations · Full text

Biochemical Markers, Gynecology, Surgery +16

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

P. Farahmand, Fernando Marín, Federico Hawkins et al. · Osteoporosis International · 2013 · 45 citations · Full text